Pharma, Biotech & AI
Recursion
A searchable company profile that connects brand discovery with related news, official links, and the Life AI Net directory.
Latest related news
Recursion Pharma director Christopher Gibson sells $144,800 in stock Investing.com
Jun 5, 2026 Recursion Pharma director Christopher Gibson sells $144,800 in stock - Investing.comRecursion Pharma director Christopher Gibson sells $144,800 in stock Investing.com
Jun 4, 2026 Recursion Pharmaceuticals Stock (RXRX) Opinions on Clinical Proof and AI Platform Advancements - Quiver QuantitativeRecursion Pharmaceuticals Stock (RXRX) Opinions on Clinical Proof and AI Platform Advancements Quiver Quantitative
Jun 4, 2026 Why Recursion Pharmaceuticals (RXRX) Is Up 9.5% After AI Pipeline Progress And Stronger-Than-Expected Q1 Results - Yahoo FinanceWhy Recursion Pharmaceuticals (RXRX) Is Up 9.5% After AI Pipeline Progress And Stronger-Than-Expected Q1 Results Yahoo Finance
Jun 2, 2026 Recursion vs. Schrodinger: Comparing Biotech and Software Drug Discovery Strategies in 2026 - News and Statistics - IndexBoxRecursion vs. Schrodinger: Comparing Biotech and Software Drug Discovery Strategies in 2026 - News and Statistics IndexBox
Jun 2, 2026 A Look At Recursion Pharmaceuticals (RXRX) Valuation As Shares Show Short Term Momentum - simplywall.stA Look At Recursion Pharmaceuticals (RXRX) Valuation As Shares Show Short Term Momentum simplywall.st
Data signals
- Category: Pharma, Biotech & AI
- External sources: 1
- Website: verified